AUTOLUS THERAPEUTICS PLC shareholders Q3 2023

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
HARBOR CAPITAL ADVISORS, INC. 286,065$666,5310.14%
Alphabet Inc. 698,262$1,626,9500.10%
Ikarian Capital, LLC 262,694$612,0780.07%
INNOVIS ASSET MANAGEMENT LLC 63,179$147,2080.06%
WEALTH EFFECTS LLC 47,000$109,5100.05%
Cormorant Asset Management, LP 392,167$913,7490.05%
Perpetual Ltd 1,973,048$4,597,2020.05%
LGT CAPITAL PARTNERS LTD. 550,000$1,281,5000.05%
EWA, LLC 18,317$67,0400.04%
UBS OCONNOR LLC 585,919$1,365,1910.03%
External links

This page lists AUTOLUS THERAPEUTICS PLC's shareholders in Q3 2023. To view AUTOLUS THERAPEUTICS PLC's shareholder history, click here.